CD274 and small cell lung carcinoma: The limitations of PD‐L1 immunohistochemical analyses and the current lack of biomarkers for ICIs in SCLC underscore the need for additional research to further investigate potential biomarkers of ICIs in SCLC and their relevance to clinical outcomes.